Mattis Dementia Rating Scale 2: screening for MCI and dementia (Q51003266)

26 March 2018

title

Mattis Dementia Rating Scale 2: screening for MCI and dementia (English)

1 reference

26 March 2018

0 references

7

1 reference

26 March 2018

author name string

Evelyne Matteau

1

1 reference

26 March 2018

Nicolas Dupré

2

1 reference

26 March 2018

Mélanie Langlois

3

1 reference

26 March 2018

Léonie Jean

4

1 reference

26 March 2018

Stéphanie Thivierge

5

1 reference

26 March 2018

Pierre Provencher

6

1 reference

26 March 2018

language of work or name

English

0 references

publication date

21 June 2011

1 reference

26 March 2018

American Journal of Alzheimer's Disease & Other Dementias

published in

1 reference

26 March 2018

volume

26

1 reference

26 March 2018

issue

5

1 reference

26 March 2018

page(s)

389-398

1 reference

26 March 2018

Mild cognitive impairment: clinical characterization and outcome

cites work

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Mild cognitive impairment as a diagnostic entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Defining mild cognitive impairment in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

The epidemiology of dementia associated with Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Evaluation of older persons with mild cognitive deficits: potential utility of magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Clinical validity of the Mattis Dementia Rating Scale in detecting dementia of the Alzheimer type: a double cross-validation and application to a community-dwelling sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

The clinical utility of the dementia rating scale for assessing Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Differentiation of the dementias of Alzheimer's and Parkinson's disease with the dementia rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Psychometric properties of a new metamemory questionnaire for older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Mild cognitive impairment: ten years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Clinical diagnostic criteria for dementia associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Screening for dementia of the alzheimer type in the community: the utility of the Clock Drawing Test

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Robust and expanded norms for the Dementia Rating Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Memory and executive function impairment predict dementia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Multiple cognitive deficits in amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Preclinical Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Early neuropsychological detection and the characteristics of Parkinson's disease associated with mild dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Selective cortical and hippocampal volume correlates of Mattis Dementia Rating Scale in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Association between cognition and function in patients with Parkinson disease with and without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511412046

21 January 2018

Identifiers

DOI

10.1177/1533317511412046

1 reference

26 March 2018

1 reference

26 March 2018